[Vaccination in the elderly].

A Kwetkat, M W Pletz
Author Information
  1. A Kwetkat: Klinik für Geriatrie, Universitätsklinikum Jena, Bachstr. 18, 07743, Jena, Deutschland, anja.kwetkat@med.uni-jena.de.

Abstract

The aging immune system, so-called immunosenescence, is well documented as the cause of increased infection rates and severe, often complicated course of infections in the elderly with increased morbidity and mortality rates. Furthermore, it can lead to decreased efficacy of vaccination. The administration of more immunogenic vaccines can be beneficial in the elderly. Implementing vaccination recommendations for the elderly by STIKO can reduce burden of infectious diseases by prevention of infection or reduction of severity of infection. The following vaccinations are recommended by STIKO for all persons aged 60 and above: annual influenza vaccination (additionally all nursing home residents independently of age), once only pneumococcal polysaccharide vaccination, completion of tetanus and diphtheria (Td) vaccination as well as regular revaccination. All adults should be vaccinated against pertussis with Tdap vaccine once. Meanwhile, pneumococcal conjugate vaccine is allowed for administration in adults but is not recommended by STIKO yet. A lifelong course of vaccination may help to attenuate the effect of immunosenescence.

References

  1. Thorax. 2012 Feb;67(2):132-8 [PMID: 22058186]
  2. Drugs. 2012 Jun 18;72(9):1243-55 [PMID: 22686616]
  3. Dtsch Med Wochenschr. 2008 Feb;133(8):358-62 [PMID: 18270917]
  4. Vaccine. 2006 Jan 23;24(4):468-75 [PMID: 16125826]
  5. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Dec;47(12):1204-15 [PMID: 15583892]
  6. Vaccine. 2011 Aug 5;29(34):5785-92 [PMID: 21624411]
  7. Vaccine. 2009 Mar 4;27(10):1504-10 [PMID: 19171174]
  8. Vaccine. 2006 Mar 6;24(10):1537-42 [PMID: 16288937]
  9. Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S82-5 [PMID: 19353477]
  10. Aging Dis. 2012 Feb;3(1):51-67 [PMID: 22500271]
  11. Eur Respir J. 2010 Sep;36(3):608-14 [PMID: 20075048]
  12. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000422 [PMID: 18253977]
  13. J Infect Dis. 2012 May 1;205(9):1408-16 [PMID: 22457293]
  14. J Am Geriatr Soc. 2012 Jul;60(7):1260-7 [PMID: 22724499]
  15. Vaccine. 2012 Feb 21;30(9):1721-8 [PMID: 22212127]
  16. J Neuroimmunol. 2003 Apr;137(1-2):1-11 [PMID: 12667642]
  17. Geriatr Gerontol Int. 2012 Apr;12(2):223-9 [PMID: 21951819]
  18. Vaccine. 2012 Nov 6;30(48):6802-8 [PMID: 23000122]
  19. Am J Geriatr Pharmacother. 2011 Dec;9(6):392-404 [PMID: 22047941]
  20. Vaccine. 2011 Jul 12;29(31):5015-21 [PMID: 21565245]
  21. Drugs Aging. 2011 Feb 1;28(2):93-106 [PMID: 21275435]
  22. CMAJ. 2009 Jan 6;180(1):48-58 [PMID: 19124790]
  23. BMC Infect Dis. 2010 Mar 18;10:73 [PMID: 20298596]
  24. Expert Opin Biol Ther. 2012 Jan;12(1):63-77 [PMID: 22074323]

MeSH Term

Diphtheria
Diphtheria Toxoid
Germany
Health Services for the Aged
Humans
Influenza Vaccines
Influenza, Human
Pertussis Vaccine
Pneumococcal Vaccines
Practice Guidelines as Topic
Tetanus
Tetanus Toxoid
Vaccination
Whooping Cough

Chemicals

Diphtheria Toxoid
Influenza Vaccines
Pertussis Vaccine
Pneumococcal Vaccines
Tetanus Toxoid

Word Cloud

Created with Highcharts 10.0.0vaccinationinfectionelderlycanSTIKOimmunosenescencewellincreasedratescourseadministrationrecommendedpneumococcaladultsvaccineagingimmunesystemso-calleddocumentedcausesevereoftencomplicatedinfectionsmorbiditymortalityFurthermoreleaddecreasedefficacyimmunogenicvaccinesbeneficialImplementingrecommendationsreduceburdeninfectiousdiseasespreventionreductionseverityfollowingvaccinationspersonsaged60above:annualinfluenzaadditionallynursinghomeresidentsindependentlyagepolysaccharidecompletiontetanusdiphtheriaTdregularrevaccinationvaccinatedpertussisTdapMeanwhileconjugateallowedyetlifelongmayhelpattenuateeffect[Vaccinationelderly]

Similar Articles

Cited By